Relevant factors influencing flatfoot in preschool-aged children

Kun-Chung Chen1, Chih-Jung Yeh, Li-Chen Tung

  • 1Institute of Medicine, Chung Shan Medical University, Taichung City, 402, Taiwan.

Insights

Flatfoot prevalence decreases with age in young children. Bilateral flatfoot risk is linked to age, obesity, gender, joint laxity, and W-sitting, while unilateral flatfoot has different risk factors.

Area of Science:

  • Pediatric Orthopedics
  • Biomechanical Analysis
  • Child Development

Background:

  • Flatfoot is a common condition in preschool-aged children, with varying risk factors.
  • Understanding the influence of intrinsic and extrinsic factors on flatfoot development is crucial for early intervention.

Purpose of the Study:

  • To investigate the association between age, gender, obesity, joint laxity, and W-sitting habit with flatfoot in preschool children.
  • To differentiate risk factors for unilateral versus bilateral flatfoot.

Main Methods:

  • A cross-sectional study involving 1,598 preschool children (3-6 years old) in Taiwan.
  • Children were categorized into normal, unilateral flatfoot, and bilateral flatfoot groups.
  • Multinomial logistic regression analysis was employed to identify influencing factors.

Main Results:

  • Flatfoot prevalence significantly decreased with age; bilateral flatfoot was 54.5% in 3-year-olds versus 21% in 6-year-olds.
  • Bilateral flatfoot risk increased with obesity and was higher in boys, decreasing with age.
  • Higher joint laxity and W-sitting habit were associated with increased risk in both flatfoot groups; age and obesity were not significant for unilateral flatfoot.

Conclusions:

  • Age, gender, obesity, joint laxity, and W-sitting are significantly associated with bilateral flatfoot in preschool children.
  • Unilateral flatfoot presents different risk profiles compared to normal feet and bilateral flatfoot, warranting further investigation.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...